Description

NSE notifies listing and trading of 26,57,57,500 bonus equity shares of Anlon Healthcare Limited (AHCL) effective April 28, 2026, following a bonus issue with record date of April 24, 2026.

Summary

NSE has notified the listing and commencement of trading of 26,57,57,500 equity shares of Anlon Healthcare Limited (Symbol: AHCL) issued pursuant to a bonus issue. The shares will be admitted to dealings on the NSE Capital Market segment effective April 28, 2026, under Circular Ref. No. 0662/2026 (Download Ref No: NSE/CML/73841).

Key Points

  • Anlon Healthcare Limited (AHCL) bonus shares will be listed and tradeable on NSE from April 28, 2026
  • Total bonus shares to be listed: 26,57,57,500 (approximately 265.76 million shares)
  • ISIN for the bonus shares: INE0Y8W01025
  • Distinctive number range: 265757501 to 531515000
  • Issued under Regulation 3.1.1 of the NSE (Capital Market) Trading Regulations Part A

Regulatory Changes

No new regulatory changes. This circular is issued in pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, which governs the admission of securities to dealings on the exchange.

Compliance Requirements

  • Members are notified that for trading purposes, the security shall be identified only by its designated codes (Symbol: AHCL)
  • No specific compliance action required from members beyond standard trading protocols for newly listed securities

Important Dates

  • Circular Date: April 22, 2026
  • Record Date: April 24, 2026
  • Deemed Date of Allotment: April 27, 2026
  • Effective Date for Trading: April 28, 2026

Impact Assessment

The listing of ~265.76 million bonus shares will increase the total share count of Anlon Healthcare Limited significantly. Existing shareholders as of the record date (April 24, 2026) will receive bonus shares, which may lead to a proportional adjustment in share price on the ex-bonus date. Traders and investors holding AHCL should be aware of the increased float and potential price adjustment. The circular has no broader market-wide impact and is routine in nature.

Impact Justification

Routine bonus issue listing notification affecting existing AHCL shareholders with a significant share count addition of ~265 million shares; medium impact due to dilution effect on share price and relevance to current holders.